<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1402256900
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2003
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        ZOVIRAX 200MG\5ML SUSP
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        ACYCLOVIR
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        40
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Oral suspension
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        125
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bottle
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        75.30
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="ASPEN" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            ASPEN
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 354]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Glaxo Saudi Arabia Ltd
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J05AB01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>1.&nbsp;&nbsp; </strong><em>ZOVIRAX </em>contains a medicine called acyclovir. This belongs to a group of medicines called antivirals. It works by stopping the growth of certain viruses.</p><p><em>ZOVIRAX </em>can be used to:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; treat chicken-pox and shingles</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; help reduce the nerve pain that can exist after the shingles rash has cleared</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; treat cold sores, genital herpes and other herpes simplex infections</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; stop cold sores, genital herpes and other herpes virus infections from coming back after you have had them.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; prevent herpes virus infections in people whose immune systems work less well, which means their bodies are less able to fight infections.</p><p>Ask your doctor or pharmacist if you would like any further explanation about these uses.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Don&rsquo;t take <em>ZOVIRAX</em></strong></p><p>If you are <strong>allergic </strong>(<em>hypersensitive</em>) to acyclovir, valaciclovir or any other ingredients of</p><p><em>ZOVIRAX </em>(listed in Section 6).</p><p>&egrave; if you think this applies to you, <strong>don&rsquo;t take <em>ZOVIRAX </em></strong>until you have checked with your doctor.</p><p>&nbsp;</p><p><strong>Take special care with <em>ZOVIRAX</em></strong></p><p>Before you take <em>ZOVIRAX </em>your doctor needs to know:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have <strong>kidney disease</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you are <strong>over 65 </strong>years old</p><p>&egrave; <strong>Check with your doctor </strong>if you think any of these may apply to you. Your doctor may lower your dose of <em>ZOVIRAX</em>.</p><p>&nbsp;</p><p>You must make sure you <strong>drink plenty of liquids such as water </strong>while you are taking</p><p><em>ZOVIRAX</em>.</p><p>&nbsp;</p><p><strong>Other medicines and <em>ZOVIRAX</em></strong></p><p>Tell your doctor or pharmacist if you&#39;re taking any other medicines, if you&rsquo;ve taken any recently, or if you start taking new ones. This includes medicines bought without a prescription.</p><p>&nbsp;</p><p>Pregnancy and breast-feeding<!--[if supportFields]><span style='mso-element:
field-begin'></span> DOCVARIABLE vault_nd_aeca8cd8-e543-465f-bc76-e648b707bdec
\* MERGEFORMAT <span style='mso-element:field-separator'></span><![endif]-->&nbsp;<!--[if supportFields]><span style='mso-element:
field-end'></span><![endif]--></p><p>If you are <strong>pregnant</strong>, or <strong>think you could be, </strong>or if you are <strong>planning to become pregnant</strong>, <strong>don&rsquo;t take <em>ZOVIRAX </em></strong>without checking with your doctor. <strong>Your doctor </strong>will consider the benefit to you and the risk to your baby of taking <em>ZOVIRAX </em>while you&#39;re pregnant.</p><p>&nbsp;</p><p>The ingredients in <em>ZOVIRAX </em>can pass into breast milk. <strong>If you are breast-feeding, you must check with your doctor </strong>before you take <em>ZOVIRAX</em>.</p><p>&nbsp;</p><p>Effect on Driving and using machines<!--[if supportFields]><span
style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_bd58d89c-645d-4ce7-a495-d08ab7eb14e7 \* MERGEFORMAT <span
style='mso-element:field-separator'></span><![endif]-->&nbsp;<!--[if supportFields]><span style='mso-element:
field-end'></span><![endif]--></p><p>Some side effects such as feeling drowsy or sleepy may impair your ability to concentrate and react. Make sure you are not affected before you drive or operate machinery</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>How much to take<!--[if supportFields]><span
style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_82e21e26-44d8-4981-8537-a79fc1ea921c \* MERGEFORMAT <span
style='mso-element:field-separator'></span><![endif]-->&nbsp;<!--[if supportFields]><span style='mso-element:
field-end'></span><![endif]--></p><p><strong>Always take <em>ZOVIRAX </em>exactly as your doctor has told you to. </strong>Check with your doctor or pharmacist if you&#39;re not sure.</p><p>&nbsp;</p><p>Your doctor will decide on the correct dose to take, how often and for how long, depending on:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; the type of infection you have</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; whether it is to treat the infection or to stop it coming back</p><p>How to take<!--[if supportFields]><span
style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_7102e3e0-9cf8-4d7e-bea0-a80b2defc0b4 \* MERGEFORMAT <span
style='mso-element:field-separator'></span><![endif]-->&nbsp;<!--[if supportFields]><span style='mso-element:
field-end'></span><![endif]--></p><p>Take <em>ZOVIRAX </em>by mouth.</p><p>&nbsp;</p><p>Always shake the bottle before use.</p><p>&nbsp;</p><p><strong>If you forget to take <em>ZOVIRAX</em></strong></p><p>Take <em>ZOVIRAX </em>as soon as you remember, however if it is nearly time for your next dose skip the missed dose.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Don&rsquo;t take a double dose </strong>to make up for a missed dose.</p><p><strong>If you take too much <em>ZOVIRAX</em></strong></p><p>If you accidentally take too much <em>ZOVIRAX</em>, <strong>contact your doctor or pharmacist for advice.</strong></p><p>If you have taken too much <em>ZOVIRAX </em>you may:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feel sick (<em>nausea</em>), have a headache or vomit</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feel confused or agitated</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; see or hear things that aren&rsquo;t really there (<em>hallucinations</em>)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; have fits (<em>seizures</em>)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; become unconscious (<em>coma</em>).</p><p>&egrave; Ask your doctor or pharmacist for advice.<!--[if supportFields]><span style='mso-element:
field-end'></span><![endif]--></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, <em>ZOVIRAX </em>can cause side effects, but not everybody gets them.</p><p>&nbsp;</p><p><strong>Severe allergic reactions: </strong>These are rare (these may affect <strong>up to 1 in 1,000 </strong>people) taking <em>ZOVIRAX</em>. Signs include:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; itchy, bumpy rash (<em>hives</em>)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; swelling, sometimes of the face or mouth (<em>angioedema</em>), causing difficulty in breathing</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; collapse.</p><p>&egrave; <strong>Contact a doctor immediately </strong>if you get these symptoms. <strong>Stop taking</strong></p><p><strong><em>ZOVIRAX</em></strong>.</p><p>&nbsp;</p><p>Common side effects<!--[if supportFields]><span style='mso-element:field-begin'></span>
DOCVARIABLE vault_nd_f259c8de-9fb9-4393-a484-ec560e7cdc3c \* MERGEFORMAT <span
style='mso-element:field-separator'></span><![endif]-->&nbsp;<!--[if supportFields]><span style='mso-element:
field-end'></span><![endif]--></p><p>These may affect <strong>up to 1 in 10 </strong>people:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; headache</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; dizziness</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling sick (<em>nausea</em>) or being sick (<em>vomiting</em>)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; diarrhoea</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; stomach pains</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; itching, skin reaction after exposure to light (<em>photosensitivity</em>)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; lack of energy (<em>fatigue</em>)</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; high temperature (<em>fever</em>).</p><p>&nbsp;</p><p>Uncommon side effects<!--[if supportFields]><span style='mso-element:field-begin'></span>
DOCVARIABLE vault_nd_1890dae8-be50-4188-a149-d520c98d9a61 \* MERGEFORMAT <span
style='mso-element:field-separator'></span><![endif]-->&nbsp;<!--[if supportFields]><span style='mso-element:
field-end'></span><![endif]--></p><p>These may affect <strong>up to 1 in 100 </strong>people:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; itchy, bumpy rash (<em>hives</em>)<em>(urticaria)</em></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; hair loss.</p><p>&nbsp;</p><p>Rare side effects<!--[if supportFields]><span
style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_570daf16-0a9d-4edf-9869-ced8fcf43761 \* MERGEFORMAT <span
style='mso-element:field-separator'></span><![endif]-->&nbsp;<!--[if supportFields]><span style='mso-element:
field-end'></span><![endif]--></p><p>These may affect <strong>up to 1 in 1,000 </strong>people:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shortness of breath</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; effects on blood and urine tests</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; swelling of the face, lips, mouth, tongue or throat <em>(angioedema)</em></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; increases in the enzymes that work in the liver</p><p>&nbsp;</p><p>Very rare side effects<!--[if supportFields]><span style='mso-element:field-begin'></span>
DOCVARIABLE vault_nd_7ee062d2-5920-4f22-b03e-4b1da71d4b41 \* MERGEFORMAT <span
style='mso-element:field-separator'></span><![endif]-->&nbsp;<!--[if supportFields]><span style='mso-element:
field-end'></span><![endif]--></p><p>These may affect <strong>up to 1 in 10,000 </strong>people:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling agitated or confused</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling shaky, unsteady and a lack of co-ordination <em>(ataxia)</em></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; difficulty speaking or hoarseness <em>(dysarthria)</em></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; seeing or hearing things that are not really there (<em>hallucinations</em>)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fits <em>(seizures)</em></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling drowsy or sleepy</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inability to think or judge clearly or concentrate</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; disturbances of behaviour, speech and eye movements <em>(encephalopathy)</em></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; unconsciousness (<em>coma</em>)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; yellowing of the skin and whites of the eyes (<em>jaundice</em>), inflammation of the liver</p><p><em>(hepatitis</em>)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; pain in the lower back, the kidney area of the back or just above the hip (<em>renal pain</em>), kidney failure</p><p>&nbsp;</p><p>Very rare side effects that may show up in blood tests<!--[if supportFields]><span style='mso-element:field-begin'></span>
DOCVARIABLE vault_nd_ef0b5594-97eb-416e-9596-f08acb96fc4d \* MERGEFORMAT <span
style='mso-element:field-separator'></span><![endif]-->&nbsp;<!--[if supportFields]><span style='mso-element:
field-end'></span><![endif]--></p><p>These may affect <strong>up to 1 in 10,000 </strong>people:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; reduced numbers of red blood cells (<em>anaemia</em>)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; reduced numbers of white blood cells <em>(leukopenia)</em></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; reduced numbers of blood platelets (cells that help blood to clot)</p><p><em>(thrombocytopenia)</em></p><p><em>&nbsp;</em></p><p>If you get side effects<!--[if supportFields]><span
style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_4f64401d-eaaa-49a0-904b-a8b103029a14 \* MERGEFORMAT <span
style='mso-element:field-separator'></span><![endif]-->&nbsp;<!--[if supportFields]><span style='mso-element:
field-end'></span><![endif]--></p><p>&egrave; <strong>Tell your doctor or pharmacist </strong>if any of the side effects become <strong>severe or troublesome</strong>, or if you notice any side effects not listed in this leaflet.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&middot; Keep out of reach and sight of children.<!--[if supportFields]><span style='mso-element:field-begin'></span>
DOCVARIABLE vault_nd_128e854d-f17a-4fee-a712-7e787337edfb \* MERGEFORMAT <span
style='mso-element:field-separator'></span><![endif]-->&nbsp;<!--[if supportFields]><span style='mso-element:
field-end'></span><![endif]--></p><p>&middot; Do not use ZOVIRAX Suspension after the expiry date which is stated on the pack after &lsquo;Exp&rsquo;.</p><p>&middot; Store ZOVIRAX Suspension at below 25&deg;C.</p><p>&middot; If your doctor tells you to stop taking ZOVIRAX Suspension, it is important to return any Suspension which are left over to your pharmacist.</p><p>&middot; Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>What ZOVIRAX Suspension contains<!--[if supportFields]><span style='mso-element:
field-begin'></span> DOCVARIABLE vault_nd_13ad2aee-9c45-457b-a5b8-45dc220546cd
\* MERGEFORMAT <span style='mso-element:field-separator'></span><![endif]-->&nbsp;<!--[if supportFields]><span style='mso-element:
field-end'></span><![endif]--></p><p>&middot; Active ingredients:</p><p><strong>ZOVIRAX </strong><em>Suspension 200 mg </em>contains 200 mg Acyclovir in each 5 mL.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other ingredients include:</p><p>Methyl Parahydroxybenzoate, Propyl Parahydroxybenzoate, Banana Flavour, Vanillin, Glycerol, Sorbitol 70 Percent non crystallising, Dispersible Cellulose.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                What ZOVIRAX Suspension looks like and contents of the pack
An oral suspension. It comes in an amber glass bottle holding 125 ml of suspension and may be supplied with a measuring cup or double- ended spoon.

ZOVIRAX is a trademark owned by or licensed to GSK group of companies
© 2021 GlaxoSmithKline, all rights reserved.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Manufactured by:<!--[if supportFields]><span style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_784b2684-4281-4892-ad7d-d8ae96a55a62 \* MERGEFORMAT <span
style='mso-element:field-separator'></span><![endif]-->&nbsp;<!--[if supportFields]><span style='mso-element:
field-end'></span><![endif]--></p><p>Aspen Bad Oldsloe Gmbh, Bad Oldsloe, Germany</p><p>Marketing Authorisation Holder<!--[if supportFields]><span style='mso-element:field-begin'></span>
DOCVARIABLE vault_nd_1eac2ad6-051e-463b-8a61-5a51a98a83b9 \* MERGEFORMAT <span
style='mso-element:field-separator'></span><![endif]-->&nbsp;<!--[if supportFields]><span style='mso-element:
field-end'></span><![endif]--></p><p>Glaxo Saudi Arabia Ltd, Jeddah*, Saudi Arabia</p><p>*member of the GSK group of companies</p><p>&nbsp;</p><p>For any information about this medicinal product, please contact:<!--[if supportFields]><span
style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_0b322b41-30c9-47b2-8f6d-6316ebb6c785 \* MERGEFORMAT <span
style='mso-element:field-separator'></span><![endif]-->&nbsp;<!--[if supportFields]><span style='mso-element:
field-end'></span><![endif]--></p><p>GlaxoSmithKline - Head Office, Jeddah<!--[if supportFields]><span style='mso-element:field-begin'></span>
DOCVARIABLE vault_nd_34235a19-17fa-487f-bf7d-b62b7fa95b22 \* MERGEFORMAT <span
style='mso-element:field-separator'></span><![endif]-->&nbsp;<!--[if supportFields]><span style='mso-element:
field-end'></span><![endif]--></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tel:&nbsp; +966-12-6536666</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mobile: +966-56-904-9882</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Email: gcc.medinfo@gsk.com</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://gskpro.com/en-sa/<u> </u></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; P.O. Box 55850, Jeddah 21544, Saudi Arabia</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:505px"><tbody><tr><td style="vertical-align:top; width:502px"><p>&nbsp;</p><p><strong>To report any side effect(s):</strong></p><p><strong><em>Kingdom of Saudi Arabia</em></strong></p><p><strong>-National Pharmacovigilance centre (NPC)</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SFDA Call Centre: 19999</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://ade.sfda.gov.sa</p><p><strong>-GlaxoSmithKline - Head Office, Jeddah</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tel:&nbsp; +966-12-6536666</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mobile: +966-56-904-9882</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Email: saudi.safety@gsk.com<u>&nbsp; </u></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://gskpro.com/en-sa/<u> </u></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; P.O. Box 55850, Jeddah 21544, Saudi Arabia</p><p>&nbsp;</p><p>&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>&nbsp;</strong></p><p><strong>THIS IS A MEDICAMENT</strong></p><p>-&nbsp; Medicament is a product which affects your health, and its consumption contrary to instructions is dangerous for you.</p><p>-&nbsp; Follow strictly the doctor&rsquo;s prescription, the method of use and the instructions of the pharmacist who sold the medicament.</p><p>-&nbsp; The doctor and the pharmacist are experts in medicine, its benefits and risks.</p><p>-&nbsp; Do not by yourself interrupt the period of treatment prescribed for you.</p><p>-&nbsp; Do not repeat the same prescription without consulting your doctor.</p><p>-&nbsp; Keep all medicine out of reach of children</p><p>&nbsp;</p><p>Council of Arab Health Ministers Union of Arab Pharmacists</p><p>&nbsp;</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Version Number: GDS 31 
Date of issue: 03 April 2020
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL"><strong>زوڤيراكس </strong>يحتوي على دواء يدعى أسايكلوڤير. ينتمي إلى مجموعة من الأدوية تدعى مضادات الڤيروسات. ويزاول مفعوله عن ط يرق وقف نمو بعض الڤيروسات.</p><p dir="RTL"><strong>زوڤيراكس </strong>يجوز استعماله في الحالات التالية:</p><p dir="RTL">1.&nbsp;&nbsp;&nbsp;&nbsp; &middot; علاج عدوى الجديري المائي والهرپس النطاقي.</p><p dir="RTL">2.&nbsp;&nbsp;&nbsp;&nbsp; &middot; يساعد على تخفيف الألم الناتج عن العصب الذي قد يستمر بعد اختفاء الطفح الناتج من الهربس النطاقي.</p><p dir="RTL">3.&nbsp;&nbsp;&nbsp;&nbsp; &middot; علاج قرحة البرد، اله رپس التناسلي والأنواع الأخرى من عدوى ڤيروس الهرپس سيمللكس.</p><p dir="RTL">4.&nbsp;&nbsp;&nbsp;&nbsp; &middot; تمنع قرحة البرد، اله رپس التناسلي والأنواع الأخرى من عدوى ڤيروس الهرپس سيمللكس من العودة مرة أخرى بعد الإصابة بها.</p><p dir="RTL">5.&nbsp;&nbsp;&nbsp; &middot; الوقاية من عدوى فيروس الهرپس لدى الأشخاص ذوي نظام مناعي يعمل بكفاءة قليلة، والذي يعني أن أجسامهم لديها قدرة أقل على مكافحة العدوى.</p><p dir="RTL">اسأل الطبيب أو الصيدلي إذا أردت المزيد من الشرح لدواعي الاستعمال التي ورد ذكرها.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>لا يجوز تناول </strong><strong>زوڤيراكس</strong><strong>:</strong></p><p dir="RTL">إذا كنت <strong>مصاباً بحساسية </strong><strong>)</strong>مفرط الحساسية( للأسايكلوڤير، أو الڤالاسايكلوڤير، أو أي من المكونات الأخرى <strong>بزوڤيراكس </strong><strong>)</strong>مدرجة بالفقرة 6(.</p><p dir="RTL">&ccedil; إذا كنت تعتقد أن ذلك ينطبق عليك، <strong>لا تتناول زوڤيراكس </strong>حتى تراجع طبيبك.</p><p dir="RTL"><strong>يجب توخي الحذر الشديد عند استعمال </strong><strong>زوڤيراكس</strong></p><p dir="RTL">قبل تناول <strong>زوڤيراكس </strong>يحتاج الطبيب إلى أن يعر :</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من مرض بالكلى.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان سنك يزيد عن 65 عاما .</p><p dir="RTL">&ccedil;<strong>يرجى مراجعة طبيبك </strong>في حالة اعتقادك ما إذا كان أي من ذلك ينطبق عليك، فقد يقلل طبيبك جرعة <strong>زوڤيراكس </strong>الخاصة بك .</p><p dir="RTL">يجب عليك التأكد من تناول كمية وافرة من السوائل مثل الماء أثناء تناولك <strong>زوڤيراكس</strong><strong>.</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>تناول أدوية أخرى مع زوڤيراكس</strong></p><p dir="RTL">يرجى إبلاغ الطبيب أو الصيدلي إذا كنت تتناول أو تناولت مؤخرا أية أدوية أخرى. أو بدأت بتناول أدوية جديدة. ومن جملتها أدوية اشتريتها بدون وصفة طبية.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>الحمل والرضاعة الطبيعية</strong></p><p dir="RTL">إذا كُنتِ <strong>حامل، </strong>أو <strong>تعتقدين أنك حامل، </strong>أو كنت <strong>تخططين للحمل</strong>، ، <strong>لا تتناولي زوڤيراكس </strong>بدون الرجوع إلى الطبيب، سو يأخذ طبيبك في الإعتبار الفوائد التي ستعود عليكِ والأخطار على طفلك من تناول <strong>زوڤيراكس </strong>أثناء حملك.</p><p dir="RTL"><strong>مكونات زوڤيراكس </strong>يمكن أن تنتقل إلى حليب الأم، <strong>إذا كنت تقومين بالرضاعة الطبيعية، يجب استشارة الطبيب </strong>قبل تناول <strong>زوڤيراكس</strong>.</p><p dir="RTL"><strong>التأثيرات على القدرة على قيادة السيارات واستعمال الماكينات</strong></p><p dir="RTL">بعض الأعراض الجانبية مثل الإحساس بالنعاس أو النوم قد يضعف قدرتك على التركيز والتفاعل، يرجى التأكد من عدم التأثر قبل القيادة أو تشغيل الماكينات.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>الكمية الواجب تناولها</strong></p><p dir="RTL"><strong>زوڤيراكس </strong>يجب تناوله دائما وفقا لتعليمات الطبيب. يجب الرجوع إلى الطبيب أو الصيدلي إذا لم تكن متأكد ا .</p><p dir="RTL">الطبيب سو يقرر الجرعة الصحيحة الواجب تناولها، وعدد المرات والمدة، اعتمادا على:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نوع العدوى التي أصبت بها</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;ما إذا كانت هذه الجرعة لوقف العدوى أو لمنعها من المعاودة</p><p dir="RTL"><strong>كيفية تناول </strong><strong>زوڤيراكس</strong></p><p dir="RTL">يجب تناول زوڤيراكس عن طريق الفم</p><p dir="RTL">دائما قم برج القارورة قبل الإستعمال.</p><p dir="RTL"><strong>إذا نسيت تناول </strong><strong>زوڤيراكس</strong></p><p dir="RTL">يجب تناول <strong>زوڤيراكس </strong>في أسرع وقت ممكن، ولكن إذا حان الوقت تقريبا لتناول جرعة تالية فتجاوز الجرعة المنسية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا<strong> يجوز تناول جرعة مضاعفة </strong>للتعويض عن جرعة فائتة.</p><p dir="RTL"><strong>إذا تناولت أكثر مما يجب تناوله من </strong><strong>زوڤيراكس</strong></p><p dir="RTL">إذا تناولت أكثر مما يجب تناوله من <strong>زوڤيراكس </strong>عن طريق الخطأ، يرجى مراجعة الطبيب أو الصيدلي لأخذ المشورة.</p><p dir="RTL">إذا تناولت أكثر مما يجب تناوله من زوڤيراكس قد يحدث لك:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تشعر بالتوعك (غثيان)، يصيبك صداع أو قيء</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>تشعر بالارتباك أو الاضطراب</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; رؤية أو سماع أشياء غير حقيقية (هلوسة(</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نوبات (نوبات صرع(</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تصبح غير واعي (غيبوبة(</p><p dir="RTL">&ccedil; <strong>اسأل طبيبك أو الصيدلي لأخذ النصيحة</strong><strong>.</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">كشأن كافة الأدوية، <strong>زوڤيراكس </strong>قد يسبب آثارا جانبية، إلا أنها لا تصيب كل فرد.</p><p dir="RTL"><strong>ردود فعل تحسسية خطيرة: </strong>هذه الآثار تكون نادرة <strong>(</strong>قد تصيب <strong>حتى فرداً واحداً من كل 1000 </strong>فرد<strong>) </strong>يتناولون زوڤيراكس. العلامات تتضمن<strong>:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي مرتفع مثير للحكة (شرى).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورم بعض الأحيان يكون في الوجه أو الفم (وذمة وعائية)، تتسبب في صعوبة التنفس.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انهيار.</p><p dir="RTL"><strong>&ccedil;&nbsp;&nbsp; </strong><strong>اتصل بطبيب فور اً </strong>إذا أصبت بهذه الأعراض. <strong>توقف عن تناول زوڤيراكس</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>آثار جانبية شائعة</strong></p><p dir="RTL">قد تصيب <strong>حتى فرداً واحداً من كل 10 </strong>أفراد</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صداع</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;دوخة</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;شعور بالإعياء (غثيا)، حدوث إعياء (قيء(</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;إسهال</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;ألم بالمعدة</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;حكة، تفاعل جلدي بعد التعرض للضوء (حساسية ضوئية).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;نقص الطاقة (تعب(</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;ارتفاع حرارة الجسم (حمى(</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>آثار جانبية غير شائعة</strong></p><p dir="RTL">قد تصيب <strong>حتى فرداً واحداً من كل 100 </strong>فرد</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي مرتفع مثير للحكة (شرى) (أرتيكاريا(</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تساقط الشعر</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>آثار جانبية نادرة</strong></p><p dir="RTL">قد تصيب <strong>حتى فرداً واحداً من كل 1000 </strong>فرد</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضيق النفس.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تأثير على نتائج اختبارات الدم والبول.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورم الوجه، الشفاه، الفم، اللسان أو الحلق )وذمة وعائية(.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة بمستويات الإنزيمات التي تعمل في بالكبد.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>آثار جانبية نادرة جد اً</strong></p><p dir="RTL">قد تصيب <strong>حتى فرداً واحداً من كل 10.000 </strong>فرد</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تشعر بالارتباك أو الاضطراب</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;شعور بالرعشة، فقدان تناسق حركات الجسم (خلجان(</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صعوبة بالتحدث أو بحة (تلعثم(</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ر ؤية أو سماع أشياء غير موجودة بالفعل (هلوسة(</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نوبات</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; شعور بالنعاس أو النوم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدم القد رة على التفكير والحكم بوضوح أو التركيز</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; خلل في السلوك، الحديث و حركة العين (اعتلال دماغي(</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فقدان الوعي (غيبوبة(</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اصفرار الجلد أو بياض العينين (يرقان)، التهاب كبدي</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم في أسفل الظهر، منطقة الكلية في الظهر أو أعلى مفصل الفخذ مباشرة (ألم كلوي)، فشل كلوي حاد.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>آثار جانبية نادرة جدا تظهر في نتائج اختبارات الدم</strong></p><p dir="RTL">قد تصيب <strong>حتى فرداً واحداً من كل 10.000 </strong>فرد</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض مستوى خلايا الدم الحمراء (فقر دم(</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض مستوى خلايا الدم البيضاء</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض عدد الصفيحات الدموية (خلايا تساعد الدم على التخثر).</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>إذا أصبت بأي من هذه الأعراض</strong></p><p dir="RTL">&ccedil;&nbsp;&nbsp; <strong>يرجى الاتصال بالطبيب أو الصيدلي </strong>إذا أصبحت أي من <strong>الآثار الجانبية خطيرة أو سببت مشكلة</strong>، أو إذا لاحظت أية آثار جانبية غير مدرجة في هذه النشرة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>يحفظ بعيداً عن متناول ونظر الأطفال</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>زوڤيراكس </strong>لا يجوز استعماله بعد تاريخ انتهاء الصلاحية المبين على العبوة بعد كلمة &quot; Exp .&quot;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>زوڤيراكس </strong>يجب حفظه في درجة حرارة أقل من 25 &deg;م.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;إذا أخبرك الطبيب بوقف تناول معلق <strong>زوڤيراكس</strong>، فمن المهم إعادة أي كمية متبقية إلى الصيدلي.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا يجوز التخلص من الأدوية في مياه الصر الصحي أو المخلفات المنزلية. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد بحاجة إليها. هذه التدابير تساعد على وقاية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>على ماذا يحتوي زوڤيراكس</strong></p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>&nbsp;المكونات الفعالة:</p><p dir="RTL"><strong>زوڤيراكس </strong>معلق 200 ملجم يحتوي على 200 ملجم أسايكلوڤير لكل 5 مل.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المكونات الأخرى تحتوي على:</p><p dir="RTL">ميثيل باراهيدروكسيبنزوات، بروبايل باراهيدروكسيبنزوات، نكهة الموز، فانيللين، جليسيرول، سوربيتول 70 ٪ غير متبلور، سيليولوز متشتت.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>ما هو شكل زوڤيراكس ووصفه، وعلى ماذا تحتوي العبوة</strong></p><p dir="RTL">معلق للإعطاء عن طريق الفم. يأتي في زجاجة تحتوي على 125 مل من المعلق ويمكن ان تكون العبوة مزودة بكوب قياس أو ملعقة ذو نهاية مزدوجة.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">زوڤيراكس علامة تجارية مملوكة أو مرخصة ﻟﻤﺠموعة شركات جلاكسو سميث كلاين .</p><p dir="RTL">2021 &copy; جلاكسو سميث كلاين، جميع الحقوق محفوظة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>تصنيع</strong><strong>:</strong></p><p dir="RTL">أسبن باد أولد سلو جي إم بي إتش*، باد أولد سلو، ألمانيا</p><p dir="RTL"><strong>صاحبة رخصة التسويق</strong></p><p dir="RTL">جلاكسو العربية السعودية المحدودة* جدة ، المملكة العربية السعودية</p><p dir="RTL">*عضو مجموعة شركات جلاكسو سميث كلاين.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>للإستفسار عن أي معلومات عن هذا المستحضر الدوائي، يرجى الإتصال بالأرقام التالية:</strong></p><p dir="RTL">جلاكسو سميث كلاين &ndash; المكتب الرئيسي، جدة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; هاتف: 6536666<strong>-</strong>12<strong>-</strong>966<strong>+</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; جوال: 9882-904-56-966+</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>البريد الإلكتروني: gcc.medinfo@gsk.com</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>الموقع الإلكتروني:<strong> </strong>https://gskpro.com/en-sa/</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ص.ب. 55850، جدة 21544، المملكة العربية السعودية.</p><p><strong>&nbsp;</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p dir="RTL"><strong>للإبلاغ عن أي آثار جانبية:</strong></p><p dir="RTL"><strong><em>المملكة العربية السعودية</em></strong></p><p dir="RTL"><strong>- المركز الوطني للتيقظ الدوائي (</strong><strong>NPC</strong><strong>)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مركز الاتصال الموحد: 19999</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;البريد الإلكتروني: npc.drug@sfda.gov.sa</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الموقع الإلكتروني: https://ade.sfda.gov.sa</p><p dir="RTL"><strong>- جلاكسو سميث كلاين &ndash; المكتب الرئيسي، جدة.</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; هاتف: 6536666<strong>-</strong>12<strong>-</strong>966<strong>+</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; جوال: 9882-904-56-966+</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البريد الإلكتروني: saudi.safety@gsk.com</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الموقع الإلكتروني: https://gskpro.com/en-sa/</p><p dir="RTL">&bull;&nbsp;&nbsp; <strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</strong>ص.ب. 55850، جدة 21544، المملكة العربية السعودية.<strong>&nbsp; </strong></p><p dir="RTL"><strong>&nbsp;</strong></p></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p dir="RTL"><strong>إن هذا الدواء</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">- الدواء مستحضر يؤثر على صحتك، واستهلاكه خلافا للتعليمات يعرضك للخطر.</p><p dir="RTL">- اتبع بدقة وصفة الطبيب، وطريقة الإستعمال المنصوص عليها، وتعليمات الصيدلانى الذى صرفها لك.</p><p dir="RTL">- فالطبيب و الصيدلانى هما الخبيران ﺑﺎلدواء، وبنفعه و ضرره.</p><p dir="RTL">- لا تقطع مدة العلاج المحددة لك من تلقاء نفسك.</p><p dir="RTL">- لا تكرر صرف الدواء بدون استشارة الطبيب.</p><p dir="RTL">- احتفظ بجميع الأدوية بعيداً عن متناول لأطفال.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مجلس وزراء الصحة العرب</p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اتحاد الصيادلة العرب</p></td></tr></tbody></table><p><strong>&nbsp;</strong></p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            رقم الإصدار:  GDS31
تاريخ الإصدار: 03 أبريل 2020 م

        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                ZOVIRAX Oral Suspension
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Oral suspensions containing either 200 mg acyclovir per 5 mL.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Oral suspension.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>ZOVIRAX</em> oral formulations are indicated for the treatment of herpes simplex virus infections of the skin and mucous membranes including initial and recurrent genital herpes.</p><p><em>ZOVIRAX</em> oral formulations are indicated for the suppression (prevention of recurrences) of recurrent herpes simplex infections in immune-competent patients.</p><p><em>ZOVIRAX</em> oral formulations are indicated for the prophylaxis of herpes simplex infections in immune-compromised patients.</p><p><em>ZOVIRAX</em> oral formulations are indicated for the treatment of varicella infections (chicken-pox) and herpes zoster (shingles). Studies have shown that early treatment of shingles with <em>ZOVIRAX</em> has a beneficial effect on pain and can reduce the incidence of post-herpetic neuralgia (zoster-associated pain).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><!--[if !supportLists]--></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Adults</strong></p><p>Treatment of herpes simplex</p><p>For treatment of herpes simplex infections, 200 mg <em>ZOVIRAX</em> should be taken five times daily at approximately four-hourly intervals omitting the night time dose. Treatment should continue for five days but in severe initial infections may have to be extended.</p><p>In severely immune-compromised patients (e.g. after marrow transplant) or in patients with impaired absorption from the gut the dose can be doubled to 400 mg or, alternatively, intravenous dosing could be considered.</p><p>Dosing should begin as early as possible after the start of an infection; for recurrent episodes this should preferably be during the prodromal period or when lesions first appear.</p><p>Suppression of herpes simplex</p><p>For suppression of herpes simplex infections in immune-competent patients, 200 mg <em>ZOVIRAX</em> should be taken four times daily at approximately six-hourly intervals.</p><p>Many patients may be conveniently managed on a regimen of 400 mg <em>ZOVIRAX</em> taken twice daily at approximately twelve-hourly intervals.</p><p>Dosage titration down to 200 mg <em>ZOVIRAX</em> taken thrice daily at approximately eight-hourly intervals or even twice daily at approximately twelve-hourly intervals, may prove effective.</p><p>Some patients may experience break-through infections on total daily doses of 800 mg <em>ZOVIRAX</em>.</p><p>Therapy should be interrupted periodically at intervals of six to twelve months in order to observe possible changes in the natural history of the disease.</p><p>Prophylaxis of herpes simplex</p><p>For prophylaxis of herpes simplex infections in immune-compromised patients, 200 mg <em>ZOVIRAX</em> should be taken four times daily at approximately six-hourly intervals.</p><p>In severely immune-compromised patients (e.g. after marrow transplant) or in patients with impaired absorption from the gut the dose can be doubled to 400 mg or, alternatively, intravenous dosing could be considered.</p><p>The duration of prophylactic administration is determined by the duration of the period at risk.</p><p>Treatment of varicella and herpes zoster</p><p>For treatment of varicella and herpes zoster infections, 800 mg <em>ZOVIRAX</em> should be taken five times daily at approximately four-hourly intervals, omitting the night time dose. Treatment should continue for seven days.</p><p>In severely immune-compromised patients (e.g. after marrow transplant) or in patients with impaired absorption from the gut, consideration should be given to intravenous dosing.</p><p>Dosing should begin as early as possible after the start of an infection. Treatment yields better results if initiated as soon as possible after onset of the rash.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Infants and children</strong></p><p>For treatment of herpes simplex infections, and for prophylaxis of herpes simplex infections in the immune-compromised, children aged two years and over should be given adult dosages and infants and children below the age of two years should be given half the adult dose. Do not dilute the oral suspension formulation.</p><p>For treatment of varicella infections in children:</p><p>6 years and over:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 800 mg ZOVIRAX four times daily</p><p>2 - &lt; 6 years: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 400 mg ZOVIRAX four times daily</p><p>Under 2 years:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 200 mg ZOVIRAX four times daily</p><p>&nbsp;</p><p>Dosing may be more accurately calculated as 20 mg <em>ZOVIRAX</em>/kg body weight (not to exceed 800 mg) four times daily. Treatment should continue for five days.</p><p>No specific data are available on the suppression of herpes simplex infections or the treatment of herpes zoster infections in immune-competent children.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Elderly</strong></p><p>The possibility of renal impairment in the elderly must be considered and the dosage should be adjusted accordingly (<em>see Renal impairment</em>).</p><p>Adequate hydration of elderly patients taking high oral doses of <em>ZOVIRAX</em> should be maintained.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Renal impairment</strong></p><p>Caution is advised when administering <em>ZOVIRAX</em> oral formulations to patients with impaired renal function. Adequate hydration should be maintained.</p><p>In the treatment and prophylaxis of herpes simplex infections in patients with impaired renal function, the recommended oral doses will not lead to accumulation of acyclovir above levels that have been established safe by intravenous infusion. However, for patients with severe renal impairment (creatinine clearance less than 10 mL/minute) an adjustment of dosage to 200 mg twice daily at approximately twelve-hourly intervals is recommended.</p><p>In the treatment of varicella and herpes zoster infections, it is recommended to adjust the dosage to 800 mg twice daily, at approximately twelve-hourly intervals, for patients with severe renal impairment (creatinine clearance less than 10 mL/minute) and to 800 mg three times daily, at intervals of approximately eight hours, for patients with moderate renal impairment (creatinine clearance in the range 10 to 25 mL/minute).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                ZOVIRAX tablets and ZOVIRAX suspensions are contraindicated in patients known to be hypersensitive to acyclovir or valaciclovir.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Use in patients with renal impairment and in elderly patients:</em></p><p>Acyclovir is eliminated by renal clearance, therefore the dose must be reduced in patients with renal impairment (<em>see Dosage and Administration</em>). Elderly patients are likely to have reduced renal function and therefore the need for dose reduction must be considered in this group of patients. Both elderly patients and patients with renal impairment are at increased risk of developing neurological side effects and should be closely monitored for evidence of these effects. In the reported cases, these reactions were generally reversible on discontinuation of treatment (<em>see Adverse Reactions</em>).</p><p><em>Hydration status</em><strong>:</strong> Care should be taken to maintain adequate hydration in patients receiving high oral doses of acyclovir.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No clinically significant interactions have been identified.</p><p>acyclovir is eliminated primarily unchanged in the urine via active renal tubular secretion. Any drugs administered concurrently that compete with this mechanism may increase acyclovir plasma concentrations. Probenecid and cimetidine increase the AUC of acyclovir by this mechanism, and reduce acyclovir renal clearance. Similarly increases in plasma AUCs of acyclovir and of the inactive metabolite of mycophenolate mofetil, an immunosuppressant agent used in transplant patients have been shown when the drugs are coadministered. However no dosage adjustment is necessary because of the wide therapeutic index of acyclovir.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pregnancy</strong></p><p>A post-marketing acyclovir pregnancy registry has documented pregnancy outcomes in women exposed to any formulation of <em>ZOVIRAX</em>.&nbsp; The registry findings have not shown an increase in the number of birth defects amongst <em>ZOVIRAX</em> exposed subjects compared with the general population, and any birth defects showed no uniqueness or consistent pattern to suggest a common cause.&nbsp;</p><p>The use of acyclovir should be considered only when the potential benefits outweigh the possibility of unknown risks.</p><p><strong>Lactation<em> </em></strong></p><p>Following oral administration of 200 mg acyclovir five times a day, acyclovir has been detected in breast milk at concentrations ranging from 0.6 to 4.1 times the corresponding plasma levels. These levels would potentially expose nursing infants to acyclovir dosages of up to 0.3 mg/kg/day. Caution is therefore advised if <em>ZOVIRAX</em> is to be administered to a nursing woman.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The clinical status of the patient and the adverse event profile of <em>ZOVIRAX</em> should be borne in mind when considering the patient&#39;s ability to drive or operate machinery.&nbsp; There have been no studies to investigate the effect of acyclovir<em> </em>on driving performance or the ability to operate machinery. Further, a detrimental effect on such activities cannot be predicted from the pharmacology of the active substance.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The frequency categories associated with the adverse events below are estimates. For most events, suitable data for estimating incidence were not available. In addition, adverse events may vary in their incidence depending on the indication.</p><p>The following convention has been used for the classification of undesirable effects in terms of frequency:- Very common &sup3;1/10, common &sup3;1/100 and &lt;1/10, uncommon &sup3;1/1000 and &lt;1/100, rare &sup3;1/10,000 and &lt;1/1000, very rare &lt;1/10,000.</p><p><br /><strong>Blood and lymphatic system disorders</strong></p><p>Very rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Anaemia, leukopenia, thrombocytopenia.</p><p><strong>Immune system disorders</strong></p><p>Rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Anaphylaxis.</p><p><strong>Psychiatric and nervous system disorders</strong></p><p>Common:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Headache, dizziness.</p><p>Very rare: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Agitation, confusion, tremor, ataxia, dysarthria, hallucinations, psychotic symptoms, convulsions, somnolence, encephalopathy, coma.</p><p>The above events are generally reversible and usually reported in patients with renal impairment, or with other predisposing factors (<em>see Warnings and Precautions</em>).</p><p><strong>Respiratory, thoracic and mediastinal disorders</strong></p><p>Rare: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dyspnoea.</p><p><strong>Gastrointestinal disorders</strong></p><p>Common: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Nausea, vomiting, diarrhoea, abdominal pains.</p><p><strong>Hepato-biliary disorders</strong></p><p>Rare: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reversible rises in bilirubin and liver related enzymes.</p><p>Very rare: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hepatitis, jaundice.</p><p><strong>Skin and subcutaneous tissue disorders</strong></p><p>Common:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pruritus, rashes (including photosensitivity)</p><p>Uncommon:&nbsp;&nbsp;&nbsp; Urticaria. Accelerated diffuse hair loss.</p><p>Accelerated diffuse hair loss has been associated with a wide variety of disease processes and medicines, the relationship of the event to acyclovir therapy is uncertain.</p><p>Rare: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Angioedema.</p><p><strong>Renal and urinary disorders</strong></p><p>Rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increases in blood urea and creatinine.</p><p>Very rare: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Acute renal failure, renal pain.</p><p>Renal pain may be associated with renal failure.</p><p><strong>General disorders and administration site conditions</strong></p><p>Common:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fatigue, fever.</p><p><strong>To report any side effect(s):</strong></p><p><strong>&nbsp;</strong></p><p><strong><em>Kingdom of Saudi Arabia</em></strong></p><p><strong>-National Pharmacovigilance centre (NPC) </strong></p><p>SFDA Call Centre: 19999</p><p>E-mail: npc.drug@sfda.gov.sa &nbsp;</p><p>Website: https://ade.sfda.gov.sa</p><p>&nbsp;</p><p><strong>-GlaxoSmithKline - Head Office, Jeddah </strong></p><p>Tel: +966-12-6536666</p><p>Mobile : +966-56-904-9882</p><p>Email: saudi.safety@gsk.com&nbsp;</p><p>website: https://gskpro.com/en-sa/</p><p>P.O. Box 55850, Jeddah 21544, Saudi Arabia</p><p>&nbsp;</p><p><strong>For any information about this medicinal product, please contact:</strong></p><p><strong>GlaxoSmithKline - Head Office, Jeddah</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tel:&nbsp; +966-12-6536666</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mobile: +966-56-904-9882</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Email: gcc.medinfo@gsk.com</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://gskpro.com/en-sa/<u> </u></p><p>P.O. Box 55850, Jeddah 21544, Saudi Arabia</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Symptoms &amp; signs</strong></p><p><strong><em>&nbsp;</em></strong>acyclovir is only partly absorbed in the gastrointestinal tract. Patients have ingested overdoses of up to 20g acyclovir on a single occasion, usually without toxic effects.&nbsp; Accidental, repeated overdoses of oral acyclovir over several days have been associated with gastrointestinal effects (such as nausea and vomiting) and neurological effects (headache and confusion).</p><p>Overdosage of intravenous acyclovir has resulted in elevations of serum creatinine, blood urea nitrogen and subsequent renal failure.&nbsp; Neurological effects including confusion, hallucinations, agitation, seizures and coma have been described in association with intravenous overdosage.</p><p><strong>Treatment</strong></p><p><strong><em>&nbsp;</em></strong>Patients should be observed closely for signs of toxicity.&nbsp; Haemodialysis significantly enhances the removal of acyclovir from the blood and may therefore be considered a management option in the event of symptomatic overdose.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>ATC Code</p><p>Pharmacotherapeutic group: Direct acting antivirals, Nucleosides and nucleotides excl. reverse transcriptase inhibitors.</p><p>ATC code: J05AB01</p><p>Mechanism of Action</p><p>acyclovir is a synthetic purine nucleoside analogue with in vitro and in vivo inhibitory activity against human herpes viruses, including herpes simplex virus (HSV) types 1 and 2, varicella zoster virus (VZV), Epstein Barr virus (EBV) and cytomegalovirus (CMV). In cell culture, acyclovir has the greatest antiviral activity against HSV-1, followed (in decreasing order of potency) by HSV-2, VZV, EBV and CMV.&nbsp;</p><p>The inhibitory activity of acyclovir for HSV-1, HSV-2, VZV, EBV and CMV is highly selective. The enzyme thymidine kinase (TK) of normal, non- infected cells does not use acyclovir effectively as a substrate, hence toxicity to mammalian host cells is low; however, TK encoded by HSV, VZV and EBV converts acyclovir to acyclovir monophosphate, a nucleoside analogue, which is further converted to the diphosphate and finally to the triphosphate by cellular enzymes. Acyclovir triphosphate interferes with the viral DNA polymerase and inhibits viral DNA replication with resultant chain termination following its incorporation into the viral DNA.</p><p>Pharmacodynamic Effects</p><p>Prolonged or repeated courses of acyclovir in severely immune-compromised individuals may result in the selection of virus strains with reduced sensitivity, which may not respond to continued acyclovir treatment.</p><p>Most of the clinical isolates with reduced sensitivity have been relatively deficient in viral TK however, strains with altered viral TK or DNA polymerase have also been reported. In vitro exposure of HSV isolates to acyclovir can also lead to the emergence of less sensitive strains. The relationship between the in vitro determined sensitivity of HSV isolates and clinical response to acyclovir therapy is not clear.</p><p>All patients should be cautioned to ensure they avoid the potential of virus transmission, particularly when active lesions are present.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Absorption</p><p>Acyclovir is only partially absorbed from the gut. The average oral bioavailability varies between 10 and 20%. Under fasting conditions, mean peak concentrations (Cmax) of 0.4 microgram/ml are achieved at approximately 1.6 hours after a 200 mg dose administered as oral suspension or capsule. Mean peak plasma concentrations (Cssmax) increase to 0.7&nbsp;microgram/ml (3.1 micromoles) at steady state following doses of 200&nbsp;mg administered every four hours. A less than proportional increase is observed for Cssmax levels following doses of 400&nbsp;mg and 800&nbsp;mg administered four-hourly, with values reaching 1.2&nbsp;and 1.8 microgram/ml (5.3 and 8 micromoles), respectively.</p><p>Distribution</p><p><strong>The mean volume of distribution of 26 L indicates that acyclovir is distributed within total body water. Apparent values after oral administration (Vd/F) ranged from 2.3 to 17.8 L//kg. As plasma protein binding is relatively low (9 to 33%), drug interactions involving binding site displacement are not anticipated. Cerebrospinal fluid levels are approximately 50% of corresponding plasma levels at steady-state.</strong></p><p>Metabolism</p><p>Acyclovir is predominantly excreted unchanged by the kidney. The only known urinary metabolite is 9-[(carboxymethoxy) methyl]guanine, and accounts for 10-15% of the dose excreted in the urine.</p><p>Elimination</p><p>Mean systemic exposure (AUC0-&yen;) to acyclovir ranges between 1.9 and 2.2 microgram*h/mL after a 200 mg dose. In adults the terminal plasma half-life after oral administration has been shown to vary between 2.8 and 4.1 hours. Renal clearance of acyclovir (CLr= 14.3 L/h) is substantially greater than creatinine clearance, indicating that tubular secretion, in addition to glomerular filtration, contributes to the renal elimination of the drug. The half-life and total clearance of acyclovir are dependent on&nbsp;renal function. Therefore, dosage adjustment is recommended for renally impaired patients.<strong><em> </em></strong></p><p>In neonates (0 to 3 months of age) treated with doses of 10&nbsp;mg/kg administered by infusion over a one-hour period every 8 hours the terminal plasma half life was 3.8 hours.</p><p>Special Patient Populations</p><p>In patients with chronic renal failure the mean terminal half life was found to be 19.5&nbsp;hours. The mean acyclovir half life during haemodialysis was 5.7 hours. Plasma acyclovir levels dropped approximately 60% during dialysis.</p><p>In the elderly total body clearance falls with increasing age, associated with decreases in creatinine clearance, although there is little change in the terminal plasma half life.</p><p>Studies have shown no apparent changes in the pharmacokinetic behaviour of acyclovir or zidovudine when both are administered simultaneously to HIV infected patients.</p><p>Clinical Studies<!--[if supportFields]><span style='mso-element:field-begin'></span>
DOCVARIABLE vault_nd_158aa52d-4eb2-44c8-9079-3ee67ca6e9b8 \* MERGEFORMAT <span
style='mso-element:field-separator'></span><![endif]-->&nbsp;<!--[if supportFields]><span style='mso-element:
field-end'></span><![endif]--></p><p>There is no information on the effect of ZOVIRAX oral formulations on human female fertility.&nbsp; In a study of 20 male patients with normal sperm count, oral acyclovir administered at doses of up to 1g per day for up to six months has been shown to have no clinically significant effect on sperm count, motility or morphology.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The results of a wide range of mutagenicity tests in vitro and in vivo indicate that acyclovir is unlikely to pose a genetic risk to man.</p><p>Acyclovir was not carcinogenic in long-term studies in the rat and the mouse.</p><p>Largely reversible adverse effects on spermatogenesis in association with overall toxicity in rats and dogs have been reported only at doses of acyclovir greatly in excess of those employed therapeutically. Two-generation studies in mice did not reveal any effect of orally administered acyclovir on fertility.</p><p>Systemic administration of acyclovir in internationally accepted standard tests did not produce embryotoxic or teratogenic effects in rabbits, rats or mice. In a non-standard test in rats, foetal abnormalities were observed but only following such high subcutaneous doses that maternal toxicity was produced. The clinical relevance of these findings is uncertain.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Methyl Parahydroxybenzoate</p><p>Propyl Parahydroxybenzoate</p><p>Banana Flavour</p><p>Vanillin</p><p>Glycerol</p><p>Sorbitol 70 Percent non crystallising</p><p>Dispersible Cellulose</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There are no special requirements for&nbsp;use on handling of this product.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                The expiry date is indicated on the packaging.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 25&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Amber glass bottles with either a metal roll-on pilfer-proof closures or plastic child resistant closure.</p><p>or</p><p>White HDPE bottle with a plastic child resistant closure.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Oral Suspensions</p><p>For administration of 100 mg dose, the measuring device provided may be used, or alternatively a graduated syringe.</p><p>Not all presentations are available in every country.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Manufactured by:
Aspen Bad Oldsloe Gmbh, Bad Oldsloe, Germany
Marketing Authorisation Holder 
Glaxo Saudi Arabia Ltd.*, Jeddah, Saudi Arabia
*member of the GlaxoSmithKline group of companies
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Version number:  GDS31/IPI07
Date of issue: 03 April 2020
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>